A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 8,449,208 shares of ANNX stock, worth $58.9 Million. This represents 8.47% of its overall portfolio holdings.

Number of Shares
8,449,208
Previous 8,703,268 2.92%
Holding current value
$58.9 Million
Previous $62.4 Million 33.65%
% of portfolio
8.47%
Previous 9.43%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$4.33 - $6.79 $1.1 Million - $1.73 Million
-254,060 Reduced 2.92%
8,449,208 $41.4 Million
Q1 2024

May 15, 2024

BUY
$4.03 - $7.81 $2.59 Million - $5.01 Million
641,549 Added 7.96%
8,703,268 $62.4 Million
Q4 2023

Feb 13, 2024

BUY
$1.63 - $4.63 $3.85 Million - $10.9 Million
2,359,793 Added 41.39%
8,061,719 $36.6 Million
Q2 2023

Aug 14, 2023

BUY
$2.1 - $6.37 $1.71 Million - $5.19 Million
815,310 Added 16.68%
5,701,926 $20.1 Million
Q4 2022

Feb 14, 2023

BUY
$4.56 - $6.61 $5.86 Million - $8.49 Million
1,284,690 Added 35.67%
4,886,616 $25.3 Million
Q3 2022

Nov 14, 2022

BUY
$3.75 - $6.63 $1.35 Million - $2.39 Million
360,298 Added 11.11%
3,601,926 $22.3 Million
Q3 2020

Nov 16, 2020

BUY
$17.5 - $30.23 $56.7 Million - $98 Million
3,241,628 New
3,241,628 $98 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $332M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.